SAG
PFE icon

Susquehanna Advisors Group’s Pfizer PFE Stock Holding History

Susquehanna Advisors Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$144M Buy
6,000,000
+1,000,000
+20% +$26.2M 2.51% 12
2026
Q1 		$140M Sell
5,000,000
-1,800,000
-26% -$47.9M 4.61% 2
2025
Q4 		$169M Buy
6,800,000
+1,800,000
+36% +$45.4M 2.81% 12
2025
Q3 		$127M Buy
5,000,000
+870,000
+21% +$21.5M 1.95% 17
2025
Q2 		$100M Buy
+4,130,000
New +$96.3M 2.71% 8
2025
Q1 		– Sell
-3,500,000
Closed -$92.9M – 122
2024
Q4 		$92.9M Buy
+3,500,000
New +$94.9M 2.71% 9

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Susquehanna Advisors Group's PFE Position: Q2 2026 in Review

Susquehanna Advisors Group increased its Pfizer (PFE) stake by 20% in Q2 2026, buying an estimated $26.2M and bringing the position to 6,000,000 shares worth $144M. The position accounts for 2.51% of the portfolio, ranked #12.

Susquehanna Advisors Group first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. The position peaked at $169M in Q4 2025. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Susquehanna Advisors Group held 6,000,000 shares of Pfizer worth $144M as of Q2 2026.
  • Susquehanna Advisors Group bought 1,000,000 Pfizer shares in Q2 2026, an estimated $26.2M.
  • Pfizer made up 2.51% of Susquehanna Advisors Group's portfolio in Q2 2026, its #12 holding.
  • Susquehanna Advisors Group first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • Susquehanna Advisors Group's Pfizer position peaked at $169M in Q4 2025.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Susquehanna Advisors Group's 13F filing for Q2 2026, filed 14 Aug 2026.